NCT00079937 · Interventional trial
Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma
Overall registry status Completed
Phase 3
Conditions Asthma
Delaware Valley sites
- Asthma and Allergy Associates · Upland, PA · Delaware County
First posted
Registry updated
Added to the directory